Company News for Sep 10, 2021

Zacks Equity Research Published on September 10, 2021

Shares of Lululemon Athletica Inc. (LULU - Free Report) rallied 10.5% after the company reported fiscal second-quarter 2022 adjusted earnings per share of $1.65, beating the Zacks Consensus Estimate of $1.21.
RH’s (RH - Free Report) shares rose 7.8% after the company delivered fiscal second-quarter 2022 adjusted earnings per share of $8.48, surpassing the Zacks Consensus Estimate of $6.58.
HealthEquity, Inc.’s (HQY - Free Report) shares gained 4.4% after the company reported fiscal second-quarter 2022 adjusted earnings per share of $0.40, outpacing the Zacks Consensus Estimate of $0.36.
Moderna, Inc.’s (MRNA - Free Report) shares advanced 7.8% after the company announced that it is developing a single-shot vaccine that combines booster shots against COVID-19 as well as the seasonal flu, and the new vaccine is called mRNA-1073.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.